Oppenheimer & CO Inc Medpace Holdings, Inc. Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding MEDP
# of Institutions
617Shares Held
25.1MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$899 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$887 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$317 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$262 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$219 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.8B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...